Literature DB >> 15660608

Elicitation of expert judgments of uncertainty in the risk assessment of herbicide-tolerant oilseed crops.

Martin P Krayer von Krauss1, Elizabeth A Casman, Mitchell J Small.   

Abstract

One of the lay public's concerns about genetically modified (GM) organisms (GMO) and related emerging technologies is that not all the important risks are evaluated or even identified yet--and that ignorance of the unanticipated risks could lead to severe environmental or public health consequences. To some degree, even the scientists who participated in the analysis of the risks from GMOs (arguably the people most qualified to critique these analyses) share some of this concern. To formally explore the uncertainty in the risk assessment of a GM crop, we conducted detailed interviews of seven leading experts on GM oilseed crops to obtain qualitative and quantitative information on their understanding of the uncertainties associated with the risks to agriculture from GM oilseed crops (canola or rapeseed). The results of these elicitations revealed three issues of potential concern that are currently left outside the scope of risk assessments. These are (1) the potential loss of the agronomic and environmental benefits of glyphosate (a herbicide widely used in no-till agriculture) due to the combined problems of glyphosate-tolerant canola and wheat volunteer plants, (2) the growing problem of seed lot contamination, and (3) the potential market impacts. The elicitations also identified two areas where knowledge is insufficient. These are: the occurrence of hybridization between canola and wild relatives and the ability of the hybrids to perpetuate themselves in nature, and the fate of the herbicide-tolerance genes in soil and their interaction with soil microfauna and -flora. The methodological contribution of this work is a formal approach to analyzing the uncertainty surrounding complex problems.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15660608     DOI: 10.1111/j.0272-4332.2004.00546.x

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  7 in total

1.  Essential features for proactive risk management.

Authors:  Vladimir Murashov; John Howard
Journal:  Nat Nanotechnol       Date:  2009-08       Impact factor: 39.213

2.  Use (and abuse) of expert elicitation in support of decision making for public policy.

Authors:  M Granger Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

3.  Expert stakeholders' views on the management of human pharmaceuticals in the environment.

Authors:  Nora A Doerr-MacEwen; Murray E Haight
Journal:  Environ Manage       Date:  2006-09-02       Impact factor: 3.266

4.  The use of expert elicitation in environmental health impact assessment: a seven step procedure.

Authors:  Anne B Knol; Pauline Slottje; Jeroen P van der Sluijs; Erik Lebret
Journal:  Environ Health       Date:  2010-04-26       Impact factor: 5.984

5.  Mapping Uncertainties in the Upstream: The Case of PLGA Nanoparticles in Salmon Vaccines.

Authors:  Kåre Nolde Nielsen; Børge Nilsen Fredriksen; Anne Ingeborg Myhr
Journal:  Nanoethics       Date:  2011-03-29       Impact factor: 0.917

6.  Policy relevant results from an expert elicitation on the health risks of phthalates.

Authors:  Karin Elisabeth Zimmer; Arno Christian Gutleb; Solveig Ravnum; Martin Krayer von Krauss; Albertinka J Murk; Erik Ropstad; Janneche Utne Skaare; Gunnar Sundstøl Eriksen; Jan Ludvig Lyche; Janna G Koppe; Brooke L Magnanti; Aileen Yang; Alena Bartonova; Hans Keune
Journal:  Environ Health       Date:  2012-06-28       Impact factor: 5.984

7.  World Health Organization Estimates of the Relative Contributions of Food to the Burden of Disease Due to Selected Foodborne Hazards: A Structured Expert Elicitation.

Authors:  Tine Hald; Willy Aspinall; Brecht Devleesschauwer; Roger Cooke; Tim Corrigan; Arie H Havelaar; Herman J Gibb; Paul R Torgerson; Martyn D Kirk; Fred J Angulo; Robin J Lake; Niko Speybroeck; Sandra Hoffmann
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.